Valeo Pharma, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals: Major
  • ISIN: CA91915B1085
CAD
0.04
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Valeo Pharma, Inc. stock-summary
stock-summary
Valeo Pharma, Inc.
Pharmaceuticals: Major
Valeo Pharma Inc is a Canada-based specialty pharmaceutical company dedicated to the commercialization of prescription products in Canada. With a focus on neurodegenerative diseases, woman's health, and oncology and supportive care, the Company has a portfolio of products and a platform to manage these products through stages of commercialization.
Company Coordinates stock-summary
Company Details
16667 Hymus Blvd , KIRKLAND QC : H9H 4R9
stock-summary
Tel: 1 514 6938832
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Richard MacKay
Chairman of the Board
Mr. Frederic Fasano
President, Chief Operating Officer, Director
Mr. Steven Saviuk
Chief Executive Officer, Vice Chairman of the Board
Ms. Maureen Brennan
Independent Director
Mr. Vincent Hogue
Independent Director
Mr. Michel Trudeau
Independent Director
Mr. Michael Wells
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - Jul 2024)
Net Profit:
-8 Million
stock-summary
Industry

Pharmaceuticals: Major

stock-summary
Market cap

CAD 4 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.99

stock-summary
Return on Equity

50.96%

stock-summary
Price to Book

-0.07